RecruitingNCT06329414
Acceptability and Feasibility of Transcranial Magnetic Stimulation (TMS) for Depression in Multiple Sclerosis
Sponsor
University of Utah
Enrollment
12 participants
Start Date
Jan 16, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this single-arm, observational pilot study is to learn about the safety, feasibility, preliminary efficacy of TMS for the treatment of depression in people with MS. Participants will receive outpatient TMS treatment over the course of 5-6 weeks. Participants will complete validated questionnaires and exams before, during, and after treatment.
Eligibility
Min Age: 18 YearsMax Age: 75 Years
Inclusion Criteria3
- Established diagnosis of multiple sclerosis (any subtype) by 2017 McDonald criteria
- Established diagnosis of major depressive disorder (MDD) by DSM-5 criteria
- Eligible for transcranial magnetic stimulation (rTMS) for depression
Exclusion Criteria5
- MS relapse and/or steroid use within 3 months
- Active suicidal ideation
- History of seizure/epilepsy, brain tumor, or stroke
- History of bipolar disorder or psychosis
- Currently or planning to become pregnant
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06329414
Related Trials
Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
NCT000180571 location
From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis
NCT048734921 location
Upper Limb Nerve Cryoneurolysis is Non Inferior to the Usual Care and Has Therapeutic Add Value in Dealing With Shoulder Pain and Functional Problems Caused by Spasticity and Motor Impairment
NCT067824641 location
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
NCT0381634552 locations
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
NCT074776392 locations